-+ 0.00%
-+ 0.00%
-+ 0.00%

Oppenheimer Maintains Outperform on Guardian Pharmacy Service, Raises Price Target to $43

Benzinga·05/07/2026 12:59:57
Listen to the news
Oppenheimer analyst Michael Wiederhorn maintains Guardian Pharmacy Service (NYSE:GRDN) with a Outperform and raises the price target from $38 to $43.